Abstract Epoxyquinol B (EPQB) is a fungal metabolite, containing two a,b-epoxy ketones. We previously showed that EPQB inhibited the signal transduction involved in angiogenesis through the binding to cysteine residues of receptor kinases. However, the inhibitory mechanism was undefined. In this report, we found that one EPQB molecule is covalently bound to two L-cysteine molecules through two epoxide residues on EPQB. Furthermore, EPQB crosslinked binding proteins through the cysteine residues. These results suggest that EPQB inhibits receptor kinases by crosslinking with other protein or by intramolecular crosslinking.
It is well known that epoxides can be opened by direct attack of the nucleophile on the epoxide ring. Epoxide containing compounds are able to directly form stable adducts with proteins containing thiol or phenolic group, under mild experimental conditions [1] . We previously showed that epoxyquinol B (EPQB), a fungal metabolite and the epoxyquinoid containing two a ,b -epoxy ketones, inhibited angiogenesis through the covalent binding to cysteine residues of VEGFR2, EGFR, FGFR, and PDGFRb [2ϳ4] . In this paper, we report the reaction mechanism between EPQB and cysteine residues of binding proteins, resulted in crosslinking of the binding proteins.
EPQB possesses the highly reactive functional group; two a,b-epoxy ketones which could form covalent bonds with nucleophiles such as a thiol (Fig. 1A) . Therefore, we anticipated that EPQB has several reaction sites with cysteine residue of the binding protein. To investigate this possibility, we analyzed the reaction products of EPQB and L-cysteine by LC/MS analysis. EPQB and L-cysteine were incubated together in water for 10, 30, 60, and 120 minutes. Then, the products were analyzed by QTRAP LC/MS/MS system. As shown in Fig. 1B minutes, m/z: 472.0), respectively. These results suggest that one EPQB molecule is sequentially bound to two cysteine molecules through two of its reactive sites. The UV spectra of EPQB, EPQBϩ1Cys-2H 2 O, and EPQBϩ2Cys-2H 2 O show absorption maxima at 237, 225, and 220 nm, respectively (data not shown), indicating that these compounds containing the same chromophore derived from a a,b-unsaturated ketone. Therefore, it was strongly suggested that this conjugated system retained in the molecules of two reaction products and thus the reaction sites on EPQB are two epoxides. To confirm this possibility, we analyzed the structures of two reaction products. EPQB was incubated with L-cysteine for 1 and 4 hours, by 1 H-NMR. Since it was difficult to isolate enough amount of these products for NMR analysis, the reaction mixture was lyophilized, dissolved again in methanol-d 4 and prepared for the measurement of 1 H and DQF-COSY spectra by a Jeol JNM ECP-500 NMR spectrometer. The 1 H-NMR data revealed that the ratio of integration value between methyl doublets of EPQB (1.24 ppm, Jϭ6.4 Hz), and each product (product 1: 1.26 ppm, Jϭ6.4 Hz, and product 2: 1.28 ppm, Jϭ6.4 Hz) was two to one. As the 1 H signal derived from 11-H (6.4 ppm, s) was still observed in the 1 H-NMR spectra of both products, the addition site of cysteine molecule was supposed to be on two epoxide part of EPQB. (The numbering of both products was temporarily assigned on the basis of the corresponding carbon atoms of EPQB.) We focused on the analysis of the 1 H chemical shifts of epoxide parts in both reaction products. The assignments of 13-H, 14-H and 15-H were difficult because of overlapping with the background signals from the reaction mixture. On the other hand, the signals of 3-H, 4-H and 5-H of products were observed separately. The signal of 4-H of EPQB (3.80 ppm, dd, Jϭ1.4, 3.7 Hz) shifted to high magnetic field (product 1: 3.63 ppm, dd, Jϭ1.8, 3.2 Hz, product 2: 3.62 ppm, dd, Jϭ1.8, 2.8 Hz), because of the formation of the C-S bond in adducts instead of the C-O bond in EPQB. The cross peak was due to the protons attached to the carbon atoms originated from C4 and C5 of EPQB. It was clearly observed in the DQF-COSY spectrum. Furthermore, the stereo-structure of the products was investigated by the Dreiding model. It was considered that the six membered ring of the products has 3-a-OH, 4-b-H, 5-b-OH and a,bunsaturated ketone system, because of the subsequent ring opening of epoxide accompanied with the inversion of 4-H. The dihedral angle of 50ϳ55°between 3-H and 4-H and 110ϳ115°between 4-H and 5-H were correlated to J values as given in the NMR spectrum by the Karplus's correlation between dihedral angle and J values [5] . These results suggested that the initial binding site of L-cysteine in EPQB was the C-4 position. The analyses of LC/MS, UV, and NMR data indicated that one molecule of EPQB binds to two molecules of L-cysteine through its opening of the two epoxides.
When EPQB was treated with recombinant VEGFR2 kinase protein, we noticed that several ladder-like hypershifted bands appeared with EPQB-dependent manner ( Fig. 2A) . Since it was previously shown that one EPQB covalently binds to two cysteines, we anticipated that EPQB crosslinked the binding proteins through the cysteine residues. To investigate this possibility, we used cysteine/serine-mutated Vh1 related phosphatase (VHR) proteins [6, 7] as a model protein. VHR protein contains only four cysteine residues; Cys22, Cys30, Cys124, and Cys171. Therefore, we made two mutant VHR proteins, 3S and 4S; in these mutant proteins, three of the cysteines (C22/30/124) and all of the cysteines (C22/30/124/171) on VHR were replaced with serines, respectively. Wild type (WT) or each cysteine/serine mutant VHR (3S and 4S) were incubated with 10 mM EPQB in water and VHR buffer (50 mM Tris-HCl (pH 7.5) and 1.0 mM EDTA) for 1 hour. The samples were separated with SDS-PAGE and the VHR proteins were detected by western blotting analysis. As shown in Fig. 2B , ladder-like hypershifted bands were observed in EPQB-treated WT VHR proteins. On the contrary, only dimerized band of VHR was appeared when EPQB was treated with 3S mutant VHR protein which contains only one cysteine. Furthermore, no additional band was observed when EPQB was treated with 4S mutant VHR protein. The data shown in Fig. 2B was obtained in the water condition to correlate with the LC/MS experiment condition. In fact, there were no differences in the crosslinking pattern between the water and the VHR buffer conditions (data not shown). These results strongly suggest that EPQB crosslinked proteins through the cysteine residues on its target protein.
Recently, there have been a few reports on smallmolecule ligands containing two protein-binding surfaces. These ligands modulate a number of cellular processes especially signal transduction pathways. FK1012A, which is a dimer of FK506, is developed as a pharmacological mediator. It induced dimerization of the FK506-binding protein and consequently initiated the signaling cascade through the cysteine residues of NF-k B [11] . Since the active site of NF-kB contains cysteine residues, the binding and crosslinking by helenalin may affect the signaling pathway. Our results showed that one EPQB also binds to two cysteine residues in its binding protein(s), and suggests that EPQB may consequently inhibit angiogenesis signal transductions through inter/intramolecular crosslinking of the target proteins.
